Related Experiment Videos
Emergent cardiovascular risk factor: homocysteine
1College of Nursing, Kent State University, Tuscarawas Campus, New Philadelphia, OH 44663, USA.
Progress in Cardiovascular Nursing
|March 2, 2002
Summary
Elevated homocysteine, an amino acid metabolite, is a modifiable risk factor for cardiovascular disease. Understanding homocysteine metabolism and its risk factors, including intervention with B vitamins, is crucial for cardiovascular health.
Area of Science:
- Biochemistry
- Cardiovascular Medicine
- Nutritional Science
Background:
- Homocysteine is an intermediate amino acid derived from methionine metabolism.
- Elevated plasma homocysteine levels (>12 micromol/L) are linked to adverse cardiovascular outcomes.
- Cardiovascular disease remains a leading cause of mortality worldwide.
Observation:
- This review details homocysteine metabolism and its detrimental cardiovascular effects.
- Factors contributing to hyperhomocysteinemia are examined.
- Methods for measuring plasma homocysteine are discussed.
Findings:
- Identifies key risk factors associated with elevated homocysteine.
- Explores the role of B vitamin interventions in managing homocysteine levels.
- Highlights the significance of homocysteine as an independent, modifiable cardiovascular risk factor.
Implications:
- Cardiovascular nurses play a vital role in educating patients about homocysteine risks.
- Increased awareness can lead to proactive management strategies for cardiovascular disease prevention.
- Further research into homocysteine-lowering therapies may improve patient outcomes.